Please use this identifier to cite or link to this item: https://doi.org/10.1182/blood-2009-03-210377
Title: SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations
Authors: Nowak, D.
Ogawa, S.
Müschen, M.
Kato, M.
Kawamata, N.
Meixel, A.
Nowak, V.
Kim, H.S.
Kang, S.
Paquette, R.
Chang, M.-S.
Thoenissen, N.H.
Mossner, M.
Hofmann, W.-K.
Kohlmann, A.
Weiss, T.
Haferlach, T.
Haferlach, C.
Phillip Koeffler, H. 
Issue Date: 4-Feb-2010
Citation: Nowak, D., Ogawa, S., Müschen, M., Kato, M., Kawamata, N., Meixel, A., Nowak, V., Kim, H.S., Kang, S., Paquette, R., Chang, M.-S., Thoenissen, N.H., Mossner, M., Hofmann, W.-K., Kohlmann, A., Weiss, T., Haferlach, T., Haferlach, C., Phillip Koeffler, H. (2010-02-04). SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Blood 115 (5) : 1049-1053. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2009-03-210377
Abstract: To elucidate whether tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia is associated with characteristic genomic alterations, we analyzed DNA samples from 45 TKI-resistant chronic myeloid leukemia patients with 250K single nucleotide polymorphism arrays. From 20 patients, matched serial samples of pretreatment and TKI resistance time points were available. Eleven of the 45 TKI-resistant patients had mutations of BCR-ABL1, including 2 T315I mutations. Besides known TKI resistance-associated genomic lesions, such as duplication of the BCR-ABL1 gene (n = 8) and trisomy 8 (n = 3), recurrent submicroscopic alterations, including acquired uniparental disomy, were detectable on chromosomes 1, 8, 9, 17, 19, and 22. On chromosome 22, newly acquired and recurrent deletions of the IGLC1 locus were detected in 3 patients, who had previously presented with lymphoid or myeloid blast crisis. This may support a hypothesis of TKI-induced selection of subclones differentiating into immature B-cell progenitors as a mechanism of disease progression and evasion of TKI sensitivity. © 2010 by The American Society of Hematology.
Source Title: Blood
URI: http://scholarbank.nus.edu.sg/handle/10635/125454
ISSN: 00064971
DOI: 10.1182/blood-2009-03-210377
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

25
checked on Dec 11, 2018

WEB OF SCIENCETM
Citations

26
checked on Dec 11, 2018

Page view(s)

30
checked on Nov 2, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.